KN-04

KLK15

KLK15 (Kallikrein-related peptidase 15) is a member of the kallikrein subfamily of serine proteases, which are enzymes that cleave peptide bonds in proteins. The KLK15 gene is located on chromosome 19q13.3-13.4, a region that contains a cluster of 15 kallikrein genes. This gene is expressed in various tissues and has been implicated in several physiological and pathological processes, including cancer.

Structure

The KLK15 gene encodes a preproenzyme that is processed to produce the active enzyme. The protein consists of a signal peptide, a propeptide, and the mature enzyme. The mature enzyme has a typical serine protease structure, with a catalytic triad composed of histidine, aspartate, and serine residues.

Function

KLK15 is involved in the degradation of extracellular matrix components and the activation of other proteases. It plays a role in various physiological processes, including skin desquamation, semen liquefaction, and the regulation of blood pressure. KLK15 is also involved in the pathogenesis of certain diseases, particularly cancer.

Clinical Significance

KLK15 has been studied as a potential biomarker for prostate cancer. Elevated levels of KLK15 expression have been observed in prostate cancer tissues compared to normal tissues. It may also have prognostic value in other cancers, such as breast and ovarian cancer.

Regulation

The expression of KLK15 is regulated by steroid hormones, including androgens and estrogens. This regulation is mediated through hormone response elements in the promoter region of the KLK15 gene.

Research

Ongoing research is focused on understanding the precise role of KLK15 in cancer progression and its potential as a therapeutic target. Studies are also exploring the use of KLK15 as a biomarker for early detection and monitoring of cancer.

Also see

• Kallikrein
• Serine protease
• Prostate cancer
• Biomarker
• Chromosome 19